Cardioloxía

2018

1. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration

   JACC: Cardiovascular Interventions, Vol. 11, Núm. 19, pp. 1969-1978

2. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

   JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

3. A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial

   Intensive Care Medicine, Vol. 44, Núm. 11, pp. 1807-1815

4. A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: Six-month angiographic and one-year clinical results of the NIREUS trial

   EuroIntervention, Vol. 14, Núm. 1, pp. 86-93

5. A prospective study on the relevance and prognosis of atrial fibrillation patients presenting chronic obstructive pulmonary disease

   European-Society-of-Cardiology Congress

6. ASB1 differential methylation in ischaemic cardiomyopathy: Relationship with left ventricular performance in end-stage heart failure patients

   ESC Heart Failure, Vol. 5, Núm. 4, pp. 732-737

7. Actualización del abordaje terapéutico del paciente con dislipemia.

   Esmon Publicidad

8. Actualización del abordaje terapéutico del paciente con dislipemia.

   Esmon Publicidad

9. Acute and long-term outcomes of simultaneous atrioventricular node ablation and leadless pacemaker implantation

   PACE - Pacing and Clinical Electrophysiology, Vol. 41, Núm. 11, pp. 1484-1490

10. Acute muscle fatigue and CPR quality assisted by visual feedback devices: A randomized-crossover simulation trial

    PLoS ONE, Vol. 13, Núm. 9

11. Advanced heart failure: The new HFA consensus definition

    Dialogues in Cardiovascular Medicine, Vol. 23, Núm. 2, pp. 69-73

12. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 20, Núm. 11, pp. 1505-1535

13. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

14. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

15. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 19, Núm. 4, pp. 296-303

16. Anatomical and clinical predictors of valve dysfunction and aortic dilation in bicuspid aortic valve disease

    Heart, Vol. 104, Núm. 7, pp. 566-573

17. Anatomical and procedural predictors of pulmonary vein stenosis in the setting of second-generation cryoballoon ablation

    Journal of Cardiovascular Medicine, Vol. 19, Núm. 6, pp. 290-296

18. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry

    Thrombosis Research, Vol. 167, pp. 142-148

19. Another brick in the wall: The impact of ticagrelor use on the incidence of stroke in a large registry

    European Journal of Preventive Cardiology

20. Aortic Coarctation With Extensive Collateral Circulation

    Circulation. Cardiovascular imaging, Vol. 11, Núm. 8, pp. e007918